Precose - 50419-863-51 - (Acarbose)

Alphabetical Index


Drug Information of Precose

Product NDC: 50419-863
Proprietary Name: Precose
Non Proprietary Name: Acarbose
Active Ingredient(s): 25    mg/1 & nbsp;   Acarbose
Administration Route(s): ORAL
Dosage Form(s): TABLET
Coding System: National Drug Codes(NDC)

Labeler Information of Precose

Product NDC: 50419-863
Labeler Name: Bayer HealthCare Pharmaceuticals Inc.
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: NDA020482
Marketing Category: NDA
Start Marketing Date: 20080130

Package Information of Precose

Package NDC: 50419-863-51
Package Description: 100 TABLET in 1 BOTTLE (50419-863-51)

NDC Information of Precose

NDC Code 50419-863-51
Proprietary Name Precose
Package Description 100 TABLET in 1 BOTTLE (50419-863-51)
Product NDC 50419-863
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name Acarbose
Dosage Form Name TABLET
Route Name ORAL
Start Marketing Date 20080130
Marketing Category Name NDA
Labeler Name Bayer HealthCare Pharmaceuticals Inc.
Substance Name ACARBOSE
Strength Number 25
Strength Unit mg/1
Pharmaceutical Classes alpha Glucosidase Inhibitors [MoA],alpha-Glucosidase Inhibitor [EPC]

Complete Information of Precose


General Information